Impact of Prolonged COVID-19 on Accounting Estimates
First written in FY2021-Q3. 5 of 8 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
- FY2026DroppedAnnual reportThe accounting estimates based on the assumption that the novel coronavirus disease would be prolonged, which had been stated up to the previous filing, cannot be identified as a separate disclosure in this annual securities report.
- FY2023SoftenedAnnual report
「Regarding the impact of COVID-19, the Company has prepared its accounting estimates on the assumption that there will be no material impact in the next consolidated fiscal year.」
The assumption has changed from the previous fiscal year’s assumption that the effects of the infectious disease would continue into the following fiscal year to the assumption that there will be no material impact in the following consolidated fiscal year. - FY2023-Q3RestatedAnnual report
「There have been no material changes in the assumptions regarding the impact of COVID-19 described in the “Significant Accounting Estimates” section of the previous fiscal year’s securities report.」
The company has reconfirmed that there have been no material changes to the accounting assumptions and estimates concerning the impact of COVID-19. - FY2023-Q1RestatedAnnual report
「There have been no material changes in the assumptions regarding the impact of COVID-19 described in the “Significant Accounting Estimates” section of the previous fiscal year’s securities report.」
States that there have been no material changes from the previous fiscal year to the accounting assumptions concerning the impact of COVID-19. - FY2022RestatedAnnual report
「Regarding the impact of COVID-19, the Company has prepared its accounting estimates on the assumption that the impact will continue into the next consolidated fiscal year.」
The Company is making accounting estimates, including impairment assessments, on the assumption that the impact of infectious disease will continue into the next consolidated fiscal year. - FY2022-Q3RestatedAnnual report
「The Company states that there have been no material changes from the previous fiscal year's securities report in the assumptions or accounting estimates concerning the impact of the spread of COVID-19 described under Additional Information (Accounting Estimates Concerning the Impact of the Spread of COVID-19).」
The Company states that there have been no material changes in the accounting assumptions or estimates concerning the impact of COVID-19. - FY2022-Q1RestatedAnnual report
「The Company states that there have been no material changes from the previous fiscal year's securities report in the assumptions or accounting estimates concerning the impact of the spread of COVID-19 described under Additional Information (Accounting Estimates Concerning the Impact of the Spread of COVID-19).」
The Company states that there have been no material changes from the previous fiscal year in the accounting assumptions and estimates concerning the impact of infectious disease. - FY2021-Q3First statedAnnual report
「In assessing the recoverability of deferred tax assets and determining impairment losses, the Group had assumed that the impact of the spread of COVID-19 on its performance would have subsided by the third quarter of the current consolidated fiscal year and that sales and profit would thereafter be expected to return to levels seen in a typical year. Following a renewed review in light of current conditions, however, the Group revised its assumptions and prepared its accounting estimates on the basis that the impact of the spread of infection would continue until around the end of the current consolidated fiscal year.」
The Company revised its previous assumption that the impact of infectious disease would subside in the third quarter and is assessing the recoverability of deferred tax assets and determining impairment losses on the assumption that the impact will continue until around the end of the current consolidated fiscal year.